Literature DB >> 3462723

Chemical reactivity at an antibody binding site elicited by mechanistic design of a synthetic antigen.

A Tramontano, K D Janda, R A Lerner.   

Abstract

Monoaryl phosphonate esters, designated as analogs of the transition state in the hydrolysis of carboxylic esters, were synthesized and used as haptens to generate specific monoclonal antibodies. Some of these antibodies react with cognate aryl carboxylic esters to release a fluorescent alcohol. The reaction appears to be stoichiometric; however, the activity is slowly regenerated under alkaline conditions or by treatment with hydroxylamine. Specificity is rigorous for esters of p-trifluoroacetamidophenylacetic acid, demonstrating a structural correspondence with the phosphonate hapten. Saturation kinetics are observed and kinetic parameters (kmax, Vmax, and Km) are reported. The haptenic phosphonate is a competitive inhibitor of the reaction (Ki, 35 nM); whereas the carboxylate product of ester hydrolysis is a less effective inhibitor (Ki, ca. 7500 nM). Chemical modification of side chain groups in the protein show a partial reduction in activity on acylation of lysine or nitration of tyrosine and a dramatic quenching upon modification of histidine. The evidence is discussed in terms of a mechanism in which amino acids of the antibody combining site participate in nucleophilic and/or general base catalysis. The properties of this system suggest that it is an example of enzymic transacylation where a deacylation step is not catalyzed. The possibility of deriving enzymic function from immunological specificity through this approach is advanced.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3462723      PMCID: PMC386584          DOI: 10.1073/pnas.83.18.6736

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  17 in total

Review 1.  Binding energy, specificity, and enzymic catalysis: the circe effect.

Authors:  W P Jencks
Journal:  Adv Enzymol Relat Areas Mol Biol       Date:  1975

2.  Protein measurement with the Folin phenol reagent.

Authors:  O H LOWRY; N J ROSEBROUGH; A L FARR; R J RANDALL
Journal:  J Biol Chem       Date:  1951-11       Impact factor: 5.157

3.  Reversible inactivation and superactivation by covalent modification of thermolysin.

Authors:  S Blumberg; B Holmquist; B L Vallee
Journal:  Biochem Biophys Res Commun       Date:  1973-04-16       Impact factor: 3.575

4.  Tetranitromethane. A reagent for the nitration of tyrosyl residues in proteins.

Authors:  M Sokolovsky; J F Riordan; B L Vallee
Journal:  Biochemistry       Date:  1966-11       Impact factor: 3.162

5.  Phosphorus-containing inhibitors of angiotensin-converting enzyme.

Authors:  E D Thorsett; E E Harris; E R Peterson; W J Greenlee; A A Patchett; E H Ulm; T C Vassil
Journal:  Proc Natl Acad Sci U S A       Date:  1982-04       Impact factor: 11.205

6.  Inhibition of angiotensin converting enzyme by phosphonic amides and phosphonic acids.

Authors:  R E Galardy; V Kontoyiannidou-Ostrem; Z P Kortylewicz
Journal:  Biochemistry       Date:  1983-04-12       Impact factor: 3.162

7.  Artificial enzymes.

Authors:  R Breslow
Journal:  Science       Date:  1982-11-05       Impact factor: 47.728

8.  Mechanism of enzyme inhibition by phosphate esters.

Authors:  S A BERNHARD; L E ORGEL
Journal:  Science       Date:  1959-09-11       Impact factor: 47.728

9.  Aminoalkylphosphonofluoridate derivatives: rapid and potentially selective inactivators of serine peptidases.

Authors:  L A Lamden; P A Bartlett
Journal:  Biochem Biophys Res Commun       Date:  1983-05-16       Impact factor: 3.575

10.  Phosphonamidates as transition-state analogue inhibitors of thermolysin.

Authors:  P A Bartlett; C K Marlowe
Journal:  Biochemistry       Date:  1983-09-27       Impact factor: 3.162

View more
  10 in total

Review 1.  Natural catalytic antibodies.

Authors:  S Paul
Journal:  Mol Biotechnol       Date:  1996-06       Impact factor: 2.695

Review 2.  Catalytic antibodies.

Authors:  G M Blackburn; A S Kang; G A Kingsbury; D R Burton
Journal:  Biochem J       Date:  1989-09-01       Impact factor: 3.857

3.  Catalysis of a stereospecific bimolecular amide synthesis by an antibody.

Authors:  S J Benkovic; A D Napper; R A Lerner
Journal:  Proc Natl Acad Sci U S A       Date:  1988-08       Impact factor: 11.205

4.  Prodrug activation via catalytic antibodies.

Authors:  H Miyashita; Y Karaki; M Kikuchi; I Fujii
Journal:  Proc Natl Acad Sci U S A       Date:  1993-06-01       Impact factor: 11.205

Review 5.  Catalytic antibodies: a critical assessment.

Authors:  D S Tawfik; Z Eshhar; B S Green
Journal:  Mol Biotechnol       Date:  1994-02       Impact factor: 2.695

6.  Proteolytic components of serum IgG preparations.

Authors:  L Li; R Kalaga; S Paul
Journal:  Clin Exp Immunol       Date:  2000-05       Impact factor: 4.330

7.  Toward antibody-directed "abzyme" prodrug therapy, ADAPT: carbamate prodrug activation by a catalytic antibody and its in vitro application to human tumor cell killing.

Authors:  P Wentworth; A Datta; D Blakey; T Boyle; L J Partridge; G M Blackburn
Journal:  Proc Natl Acad Sci U S A       Date:  1996-01-23       Impact factor: 11.205

8.  Routes to covalent catalysis by reactive selection for nascent protein nucleophiles.

Authors:  Andrey V Reshetnyak; Maria Francesca Armentano; Natalia A Ponomarenko; Domenica Vizzuso; Oxana M Durova; Rustam Ziganshin; Marina Serebryakova; Vadim Govorun; Gennady Gololobov; Herbert C Morse; Alain Friboulet; Sudesh P Makker; Alexander G Gabibov; Alfonso Tramontano
Journal:  J Am Chem Soc       Date:  2007-11-29       Impact factor: 15.419

Review 9.  Essential Protective Role of Catalytically Active Antibodies (Abzymes) with Redox Antioxidant Functions in Animals and Humans.

Authors:  Anna S Tolmacheva; Georgy A Nevinsky
Journal:  Int J Mol Sci       Date:  2022-03-31       Impact factor: 5.923

10.  Genetic background and immunological status influence B cell repertoire diversity in mice.

Authors:  Nancy Chaaya; Melody A Shahsavarian; Irene Maffucci; Alain Friboulet; Bernard Offmann; Jean-Benoist Léger; Sylvain Rousseau; Bérangère Avalle; Séverine Padiolleau-Lefèvre
Journal:  Sci Rep       Date:  2019-10-03       Impact factor: 4.379

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.